BCLC Guidelines: Precision Planning for Liver Cancer Treatment

The BCLC Guidelines (Barcelona Clinic Liver Cancer Staging System) are widely recognized globally for staging and planning the treatment of liver cancer (HCC). These guidelines consider various factors such as tumor stage, liver function, and the patient's overall health to ensure the most effective treatment.

BCLC Staging for Liver Cancer

1. Stage 0 (Very Early Stage)

• Tumor: Single tumor < 2 cm
• Liver Function: Normal (Child-Pugh A)
• Patient Health: Fully functional (ECOG 0)

Treatment Options

• Liver Resection
• Radiofrequency Ablation (RFA)
• Liver Transplantation

2. Stage A (Early Stage)

• Tumor: Single or up to 3 tumors, each ≤ 3 cm
• Liver Function: Good (Child-Pugh A or B)
• Patient Health: Fully functional (ECOG 0)

Treatment Options

• Liver Resection
• Liver Transplantation
• Radiofrequency Ablation (RFA)

3. Stage B (Intermediate Stage)

• Tumor: Multiple tumors without vascular invasion or spread outside the liver
• Liver Function: Good (Child-Pugh A or B)
• Patient Health: Fully functional (ECOG 0)

Treatment Options

• Transarterial Chemoembolization (TACE)

4. Stage C (Advanced Stage)

• Tumor: Vascular invasion or metastasis
• Liver Function: Good (Child-Pugh A or B)
• Patient Health: ECOG 1–2

Treatment Options

• Targeted Therapy (e.g., Sorafenib, Lenvatinib)
• Immunotherapy (e.g., Atezolizumab + Bevacizumab)

5. Stage D (End-Stage)

• Tumor: Extensive disease and/or severe liver dysfunction (Child-Pugh C)
• Patient Health: ECOG 3–4

Treatment Options

• Palliative Care for symptom management and quality of life
• Giving pain medication and nutritional care